Home > Inhibitors & Agonists > Others
Cat. No. Product name CAS No.
DC10780 ALB-127158(a) Featured

ALB-127158A, also known as ALB-127158(a), is a MCH1 antagonist for the treatment of obesity.

1173154-32-9
DCAPI1243 Albendazole(Albenza)

Albendazole(Albenza)

54965-21-8
DC20174 Albiglutide Featured

Albiglutide is a glucagon-like peptide-1 agonist (GLP-1 agonist).

782500-75-8
DC21993 ALDH1A inhibitor 673A

ALDH1A inhibitor 673A (ALDH1Ai 673A) is a potent, selective, pan-ALDH1A inhibitor with IC50 of 246, 230 and 348 nM for ALDH1A1, ALDH1A2 and ALDH1A3, respectively.

109437-62-9
DC20653 ALE-0540 Featured

ALE-0540 is a nerve growth factor (NGF) antagonist that inhibits the binding of NGF to TrkA or both p75 and TrkA with IC50 of 5.88 and 3.72 uM, respectively.

234779-34-1
DCAPI1034 Alendronate (Fosamax)

Alendronate (Fosamax)

121268-17-5
DC22492 Alexamorelin Featured

Alexamorelin is a synthetic growth hormone (GH) secretagogue.

196808-85-2
DC12389 Alflutinib Featured

Alflutinib (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor, inhibits EGFR active mutations as well as T790M acquired resistant mutation.The Alflutinib free base form is not stable, so we make it the mesylate s

1869057-83-9
DC22211 ALG1001 (Risuteganib) Featured

ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis; ALG1001 inhibits an integrin-mediated pathway of the vitreoretinal interface, connecting the posterior aspect of the vitreous with the internal limiting membrane of the retina. In blocking this pathway, ALG-1001 helps to achieve vitreous breakdown and separation from the retina.

1307293-62-4
DC20056 Alicapistat (ABT-957)

Alicapistat (ABT-957) is an orally active selective inhibitor of human calpains 1 and 2 for the potential use in the treatment of Alzheimer's disease (AD).

1254698-46-8
DC23405 Alizapride

Alizapride (MS 5080) is a dopamine D2 antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting..

59338-93-1
DC23489 Alizapride hydrochloride

Alizapride (MS 5080) is a dopamine D2 antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting..

59338-87-3
DC23092 Alizarin

Alizarin has a selective and effective inhibitory activity towards cancerous cells, it acts through the inhibition of ERK phosphorylation and cell cycle arrest in the S-phase.

72-48-0
DC9338 ALK inhibitor 1 Featured

ALK inhibitor 1 is a novel and selective inhibitor for the ALK kinase.

761436-81-1
DC9339 ALK inhibitor 2 Featured

ALK inhibitor 2 is a novel and selective inhibitor for the ALK kinase.

761438-38-4
DC10582 Diroximel Fumarete(ALKS-8700) Featured

ALKS-8700 also known as diroximel fumarate, is a prodrug of monomethyl fumarate in a controlled-release formulation that rapidly and efficiently converts to MMF in the body.

1577222-14-0
DC21668 ALLO-2 Featured

ALLO-2 is a potent small molecule Smoothened (Smo) antagonist that inhibits Smo agonist Hh-Ag1.5-induced luciferase expression in TM3-Gli-Luc cells with IC50 of 6 nM.

1357350-60-7
DC12226 Alloepipregnanolone

Alloepipregnanolone, a pregnane with anesthetic, hypnotic, and sedative properties, interferes with the development of rapid tolerance to the anxiolytic effect of ethanol.

516-55-2
DC8945 Allopurinol

Allopurinol (Zyloprim) is a xanthine oxidase inhibitor with an IC50 of 7.82±0.12 μM.

315-30-0
DCAPI1097 Allopurinol Sodium (Aloprim) Featured

Allopurinol sodium is a potent xanthine oxidase inhibitor (IC50 values of 0.2 to 50 μM). Allopurinol sodium can be used for the research of hyperuricemia and gout. Antileishmanial effect[1][2].

17795-21-0
DC20171 Alloxazine;Isoalloxazine

Alloxazine is an A2 receptor antagonist, which is approximately 10-fold more selective for the A2B receptor than for the A2A receptor.

490-59-5
DC12060 all-trans-4-Oxoretinoic acid

all-trans-4-Oxoretinoic acid, an active metabolite of vitamin A, induces gene transcription via binding to nuclear retinoic acid receptors (RARs).

38030-57-8
Page 121 / Total 1150 FirstPrevNextLastGoto